GI IGNITE SESSION 5: Bonus Sessions I & J
Moderator: Jonathan A. Leighton, MD, FACG

• Integrating Lifestyle and Patient: Centered Care in IBD
• Utilization of Advanced Practice Providers (APPs) in Team-Based Care

GI IGNITE SESSION 6: Bonus Sessions K & L
Moderator: Renee L. Williams, MD, MHPE, FACG

• Colon Poop-Pourri
• Pancreatic Cancer: From Detection to Palliation

GI IGNITE SESSION 7: Bonus Sessions M & N
Moderator: Brooks D. Cash, MD, FACG

• Gastric Slowdown
• Anorectal Lowdown

GI IGNITE SESSION 8: Bonus Sessions O & P
Moderator: Nicole E. Rich, MD

• Hot Topics in Hepatology
• Management of Liver Lesions: What to Do and Where Are We Going?

• LIVESTREAM
  Plenary Session 2A
  (Abstracts 19-27)
• Plenary Session 2B
  (Abstracts 28-36)

ACG's J. Edward Berk Distinguished Lecture

Introduced By: Amy S. Oxentenko, MD, FACG, ACG President

Redesigning the Delivery of IBD Care for the Future
Corey A. Siegel, MD, MS
Describe a new approach for the delivery of multidisciplinary IBD care throughout the United States.

LIVESTREAM
Symposium 3A: IBS Showdown
Moderator: William D. Chey, MD, FACG

• SIBO: Fact or Fiction?
  Pro: Bianca W. Chang, MD
  Con: Sameer K. Berry, MD, MBA
  Illustrate the role of small intestinal bacterial overgrowth in the management of irritable bowel syndrome, balanced with the considerations of repeated treatments.
• Low FODMAPs: Panacea for IBS or Precursor to Avoidant Restrictive Eating Behaviors?
  Pro: Anthony J. Lembo, MD, FACG
  Con: Kyle D. Staller, MD, MPH
  Identify the efficacy and tolerance of a low FODMAP diet in a cohort of IBS patients, balanced with the potential for undesirable outcomes of long-term dietary restrictions.

Symposium 3B: Bridging the Gaps: Overlooked Areas in Endoscopy
Moderator: John Erikson L. Yap, MD, MBA, FACG

• Mastering Your Electrosurgical Unit: Beyond Blue and Yellow
  Norio Fukami, MD, FACG
  Explain the various electrosurgical unit settings, including their distinguishing characteristics and their clinical applications.
• Radiation Safety: Protecting You and Your Patient
  Nazia Hasan, MD
  Identify optimal strategies to minimize radiation exposure and scatter, and maximize protection to staff and patients in the era of radiation technologist shortage.
• New Devices for Your Endoscopic Toolbox
  John Erikson L. Yap, MD, MBA, FACG
  Describe new endoscopic accessories that can enhance your endoscopic practice.

Symposium 3C: Guidance and Positioning of EoE Management
Moderator: Jennifer Horsley-Silva, MD

• Pills, Pens, and Slurries: Oh My!
  Bryan G. Sauer, MD, MSc, FACG
  Discuss updates and new guidelines for EoE treatment, including available pharmaceutical therapies to optimize care.
• Beyond Inflammation: Management of Persistent Symptoms in EoE
  Jennifer Horsley-Silva, MD
  Explain the work-up and management of patients with persistent EoE symptoms despite histologic remission.
• FED Up: A Practical Guide to Diet Therapy in Eosinophilic Esophagitis
  John O. Clarke, MD, FACG
  Summarize the evidence for food elimination approaches in EoE and endoscopic assessment of remission.

• LIVESTREAM
  Plenary Session 3A
  (Abstracts 37-45)
• Plenary Session 3B
  (Abstracts 46-54)

Prospects for Improvement in Prevention, Early Detection, and Treatment of Hepatocellular Carcinoma
Lewis R. Roberts, MB, ChB, PhD, FACG
Identify, implement, and support major discoveries that hold promise for substantially reducing the global burden of illness and death from liver cancer through prevention, early diagnosis, and effective treatment.

LIVESTREAM
Symposium 4A: Which IBD Therapy Is Best for This Patient? Clinical Roundtable Discussion With the IBD Experts
Moderator: Jacob M. Skeans, MD

• Case: Overlap of Moderate Ileocolonic Crohn’s Disease and Psoriatic Arthritis
  Millie D. Long, MD, MPH, FACG
  Discuss pros and cons of up-front surgical therapy vs medical therapy in Crohn’s, and incorporating the presence of extraintestinal manifestations in a treatment plan.
• Case: Older Adult with UC and Prior Cancer
  Jordan E. Axelrad, MD, MPH, FACG
  Illustrate considerations for ulcerative colitis therapy choices in the setting of prior malignancy and older age.
• Case: Patient With IBD and Anal Cancer
  David A. Schwartz, MD, FACG
  Identify risk factors for anal cancer in IBD patients and review guideline-based recommendations for screening and managing.

Symposium 4B: From Malnutrition to Mastery: Transforming Chronic Pancreatitis Care
Moderator: Kaveh Sharzehi, MD

• Optimizing Pancreatic Enzyme Replacement Therapy in Management of Exocrine Pancreatic Insufficiency
  Anna M. Buchner, MD, PhD
  Identify key nutritional deficiencies in patients with chronic pancreatitis, optimize supplementation, and recognize pitfalls.
• Chronic Pancreatitis: How Can Scoping Help?
  Kaveh Sharzehi, MD
  Outline indications, benefits, and limitations of endoscopic therapy in patients with chronic pancreatitis.
• Painful Pancreas: Going Beyond Narcotics
  Veeral M. Oza, MD
  Summarize non-narcotic based pharmacological therapy, lifestyle modifications, and cognitive behavioral therapy options for managing pain in chronic pancreatitis.